In agreement with this, our previous studies allowed us to observe that the genetic suppression of CCL2 in the 5xFAD mouse model of Alzheimer’s disease reduces the accumulation of amyloid β plaques, the production of pro-inflammatory mediators and the neuronal damage [2]. This evidence concerns the gene CCL2 and early-onset autosomal dominant Alzheimer disease.